 |
PDBsum entry 1a0l
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
1a0l
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Human beta-Tryptase is a ring-Like tetramer with active sites facing a central pore.
|
 |
|
Authors
|
 |
P.J.Pereira,
A.Bergner,
S.Macedo-Ribeiro,
R.Huber,
G.Matschiner,
H.Fritz,
C.P.Sommerhoff,
W.Bode.
|
 |
|
Ref.
|
 |
Nature, 1998,
392,
306-311.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Human tryptase, a mast-cell-specific serine proteinase that may be involved in
causing asthma and other allergic and inflammatory disorders, is unique in two
respects: it is enzymatically active only as a heparin-stabilized tetramer, and
it is resistant to all known endogenous proteinase inhibitors. The 3-A crystal
structure of human beta-tryptase in a complex with 4-amidinophenyl pyruvic acid
shows four quasi-equivalent monomers arranged in a square flat ring of pseudo
222 symmetry. Each monomer contacts its neighbours at two different interfaces
through six loop segments. These loops are located around the active site of
beta-tryptase and differ considerably in length and conformation from loops of
other trypsin-like proteinases. The four active centres of the tetramer are
directed towards an oval central pore, restricting access for macromolecular
substrates and enzyme inhibitors. Heparin chains might stabilize the complex by
binding to an elongated patch of positively charged residues spanning two
adjacent monomers. The nature of this unique tetrameric architecture explains
many of tryptase's biochemical properties and provides a basis for the rational
design of monofunctional and bifunctional tryptase inhibitors.
|
 |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1 Solid-surface representation of the tryptase
tetramer. The colours indicate positive (blue) and negative
(red) electrostatic potential at the molecular surface. Figures
made with GRASP28. a, Front view. The four monomers (labelled A
to D) are arranged at the corners of a flat square. Horizontal
and vertical local two-fold symmetry axes, relating monomer A
(or D) with B (or C), and monomer A (or B) with D (or C),
respectively, run through the tetramer centre, as does a third,
perpendicular, axis. The four monomers leave a central pore. Two
of the four bound APPA molecules (yellow) are visible, whereas
the two others are shielded by projecting flaps. The (blue)
patches of positively charged residues at the surfaces of
monomers B and D extend towards the A-B and C-D peripheries. b,
Edge view towards the C-D dimer. The tetramer has been rotated
around a vertical axis by almost 90° compared with a, clearing
the view towards the peripheral sides of monomers C (bottom) and
D (top). The positively charged patches on both monomers extend
towards the front side (right) of D and the back side (left) of
C. An extended heparin chain of almost 100 ? could span both
patches, strengthening the small C-D and A-B contacts.
|
 |
Figure 2.
Figure 2 Ribbon representation of one tryptase monomer in the
standard orientation. Monomer A of Fig. 1a is shown after
rotation around a vertical axis by 90°
(the rotation used to create Fig. 1b). The view is towards the
active centre (represented by Ser 195, His 57 and Asp 102 as
yellow stick models), with the active-site cleft running from
left to right; the APPA molecule interacts with Asp 189 (yellow
stick models) in the S1 pocket. The six unique surface loops of
tryptase surrounding the active site and engaged in intermonomer
contacts are specifically coloured. The 147 loop is light blue;
the 70-80 loop is yellow; the 37 loop is orange; the 60 loop is
mauve; the 97 loop is green; and the 173 flap is red. All other
tryptase segments are violet. Figure produced with Insight II
(Biosym/MSI, San Diego).
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nature
(1998,
392,
306-311)
copyright 1998.
|
 |
|
|
|
|
 |